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1. Introduction 
Normal-tension glaucoma, also known as low-tension glaucoma, is defined as glaucomatous 
damage to the optic nerve and visual fields with normal diurnal values of intraocular 
pressure (IOP). The term 'low-tension glaucoma' is not often used because in most patients 
with normal-tension glaucoma, the IOP is within the higher range of normal values and 
rarely low. The diagnosis is insidious in many cases and requires a complete and thorough 
work-up to exclude other causes for optic disc and visual field abnormalities. The definition 
is problematic because the normal limits of IOP have a wide Gaussian curve range and their 
effect on the development of glaucoma varies. Some patients may retain a high IOP for 
many years without any glaucomatous damage, while others with low values of IOP may 
suffer from ongoing progressive glaucomatous disease. IOP is considered as a risk factor for 
the advancement of glaucoma even in patients with normal values of IOP, and lowering the 
IOP often protects the optic nerves (Collaborative Normal Tension Glaucoma Study Group 
[CNTGSG], 1998). Some optic nerves are more vulnerable even to low levels of IOP than 
others (Drance et al, 1973). Though many factors have been suspected and investigated, it 
appears that in addition to variability of the structure of the lamina cribrosa, vascular and 
genetic factors are most likely involved. Most authors consider normal-tension glaucoma to 
be a variant of primary open angle glaucoma (POAG) (Caprioli & Spaeth, 1984; Chumbley & 
Brubaker, 1976); others rely on characteristic clinical features of many normal-tension 
glaucoma patients to consider it a distinct entity (Caprioli & Spaeth, 1984; Shields, 2008). The 
debate is ongoing and will probably continue to be the subject of research for many years. 
2. Pathogenic theories 
The optic nerve damage in normal-tension glaucoma, as in POAG, follows a cascade of 
pathophysiological events that includes impaired axonal transport, ischemia and free radical 
formation that leads to apoptosis (Harris et al., 2005). The mechanical theory is based on the 
assumption that high IOP reduces the axoplasmic axonal flow by causing direct pressure on 
the axons, resulting in damage to the nerves. Structural differences in the appearance of the 
optic nerve discs and elastin fibers in glaucoma patients also support the mechanical theory 
(Dandona et al., 1990; Quigley et al., 1994). The pressure gradient over the optic disc should 
also be considered, as chronic low intra-cranial pressure may result in a pressure difference 
that can affect the axoplasmic outflow and lead to glaucomatous progression in normal-
tension glaucoma patients.  
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On the other hand, the vascular ischemic theory suggests that low perfusion to the optic 
nerve is a major factor in the process of glaucomatous damage. This is supported by many 
articles that emphasize the importance of low ocular perfusion pressure and blood pressure 
in the development of POAG (Caprioli & Coleman, 2010). Blood supply to the optic nerve is 
derived through the ophthalmic artery mainly through the pial system and posterior ciliary 
arteries, but also from the central retinal artery. Several methods have been used to evaluate 
the blood flow and resistance of the ophthalmic artery and choroidal vessels, and their 
relationship with glaucomatous disease progression in POAG and in normal-tension 
glaucoma patients. Ultrasound Doppler has been used to show correlation between low 
blood flow and high resistance of the ophthalmic artery, to visual field progression in POAG 
patients (Galassi et al., 2003). Scanning laser ophthalmoscope demonstrated larger fluorescein 
filling defects, correlated with low blood flow in the central retinal artery and choroidal 
vessels of normal-tension glaucoma patients compared with controls (Plange et al., 2003). 
Heidelberg retinal flowmetry has detected a reduction in neuroretinal rim blood flow in 
conjunction with visual field defects in normal-tension glaucoma patients (Sato et al., 2006). 
The future of understanding the ischemic aspect in the development of glaucoma may be by 
optical measurement of retinal vessel oxygenation. Oxygenation of retinal arteries was 
found to be lower in normal-tension glaucoma patients than in healthy subjects (Michelson 
et al., 2006). Other factors influence the perfusion of the optic nerve and participate in the 
development and progression of the disease. Hypertension leads to a greater resistance in 
small blood vessels and causes atherosclerotic changes. Hypotension, especially in the 
presence of insufficient vascular autoregulation, may participate in the development of the 
ischemia (Goldberg et al., 1981). Circadian fluctuation of mean ocular perfusion pressure 
was found to be an important clinical risk factor for severity of glaucoma in eyes with 
normal-tension glaucoma (Choi et al., 2007). Nocturnal dips have also been evaluated and 
are thought to play a role in the development of normal-tension glaucoma (Bechetoille et al., 
1995; Graham et al., 1995). Another observation that indirectly supports the vascular theory 
is that many normal-tension glaucoma patients suffer from vasospastic diseases such as 
migraine (Corbett et al., 1985; Phelps & Corbett, 1985) and Raynaud disease (Broadway & 
Drance, 1998). However, other studies found no difference in the prevalence of atherosclerotic 
vascular disease in NTG and POAG patients (Klein et al., 1993; Leighton & Phillips, 1972). 
The role of vascular disease in the pathogenesis of NTG is probably related to the reduction 
of optic nerve resistance to the IOP and this may precedes changes in vasculature that occur 
also in POAG. Many believe that both theories have a part in the pathogenesis and their 
importance in the advancement of the disease varies from patient to patient. 
3. Epidemiology 
Normal tension glaucoma has been found to be common in many population-based studies, 
though the numbers vary in different studies and populations. The main reasons for the 
variation are the difference in normal IOP range in different populations and the difficulty 
in making the diagnosis. Ruling out high-tension glaucoma by diurnal measurements was 
not performed in most of these studies. Other causes of "burned out" secondary glaucoma 
such as steroid-induced or uveitis-related glaucoma were not diagnosed and excluded in 
some studies. Large epidemiological studies in North America, Europe and Australia 
estimated the prevalence of normal-tension glaucoma to be up to half that of POAG 
(Leibowitz et al., 1980; Sommer et al., 1991). The Beaver Dam Eye Study estimated the 
prevalence of normal-tension glaucoma to be up to 1.6% in patients over 75 years of age 
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(Klein et al., 1992). In Japan the prevalence is considerably higher. The Tajimi eye study 
assessed the prevalence of POAG in patients over 40 years and found it to be 3.9%, in 92% 
the IOP was 21 mmHg or lower (Iwase et al., 2004). A nationwide survey estimated the 
normal-tension glaucoma with (IOP under 21mmHg) prevalence to be 3.5 times that of 
POAG, but these numbers are thought to be biased since normal IOP in Japan is lower than 
in the western population, averaging 10-18 mmHg. The prevalence of normal tension 
glaucoma is higher in women than in men, this and other risk factors will be discussed later 
in this chapter. Whatever the prevalence of normal tension glaucoma is in various 
populations, it is obvious that the numbers are higher than once assumed, and patients are 
actually diagnosed only when optic disc and visual field abnormalities are already present. 
4. Genetic considerations  
Family history is a major risk factor in glaucoma ,and genetic mutations related to specific 
phenotypes of glaucoma are under investigation. Such information can help diagnose and 
classify subtypes of glaucoma, and perhaps even to clarify the pathogenesis. Research may 
find ways to repair mutation in utero or early in life, before glaucomatous damage has 
occurred. Genetic research has found transmission of a NTG phenotype in only a few 
families, all of them are autosomal dominant (Bennett et al., 1989). Of the seven gene loci 
that have been linked to POAG, two genes have been identified and named TIGR/ Myocilin 
and Optineurin (Optic Neuropathy-Inducing Protein - ONTP). A specific mutation GLC1E 
locus of the ONTP was found in location 10p14-15, with autosomal dominant inheritance as 
in all POAG locui that were identified (Sarfarazi et al., 1998). ONTP is expressed in the 
retina and was found to be involved in apoptosis. The Blue Mountains Eye Study in 
Australia found that the prevalence of mutation in the ONTP gene was higher in POAG 
than in healthy subjects but the difference was not statistically significant (Baird et al., 2004). 
Reports found the ONTP mutation associated with high prevalence of POAG and NTG in 
adult Japanese patients, suggesting it may be involved in the pathogenesis of both entities 
(Fuse et al., 2004; Umeda et al., 2004). Other reports could not find OPTN mutations in NTG 
(Toda et al., 2004). Genetic screening for the gene is not an option because of the low 
incidence of the mutation. Recently another locus GLCA3 was investigated for association 
with NTG, but no statistically significant relationship was found (Kamio et al., 2009). 
5. Diagnosis and differential diagnosis 
The diagnosis of normal-tension glaucoma is illusive and requires a high degree of 
suspicion. Since IOP measurements are usually in the high teens in normal-tension 
glaucoma, routine IOP screening measurement may be deceiving. Often, the first sign is an 
abnormal optic disc or disk asymmetry suspicious of glaucomatous damage. In up to half of 
the patients repeated measurements or daily IOP curve discovers high IOP, and the 
diagnosis of POAG is made (Ito et al., 1991; Perkins, 1973). The significance of a daily IOP 
curve in the diagnosis of NTG is crucial. Few other factors must be considered. Pachymetry 
should be performed to adjust the difference between measured IOP by Goldman 
tonometry and true IOP. Ocular hypertension study (OHTS) highlighted the importance of 
thin corneas in the diagnosis of glaucoma. Thinner corneas can lead to underestimation of 
IOP, and misdiagnosis has occurred in many NTG patients compared with POAG patients 
(Morad et al., 1998). The effect of corneal hysteresis and scleral rigidity should be considered 
and Ocular Response Analyzer (ORA) can help in estimating the true IOP (Morita et al., 
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2010). Thin corneas following corneal refractive surgery and in patients after penetrating or 
lamellar keratoplasty can make the task of IOP estimation more challenging (Papastergiou et 
al., 2010; Sanchez-Naves et al., 2008). Other factors such as refraction and astigmatism 
should also be considered and ORA may achieve a better estimation of the true IOP in these 
patients (Hagishima et al., 2010). 
The controversy of whether NTG is different from POAG is demonstrated in many articles 
regarding optic disc appearance. While some studies show no difference in the optic disc 
appearance between NTG and POAG (Tomita, 2000), others found distinct characteristics 
such as thin rim that can help distinguish NTG (Caprioli & Spaeth, 1985). OCT plays a major 
role in the diagnosis and monitoring of glaucoma especially when the diagnosis is not 
certain. Measuring the RNFL thickness, optic disk cupping and their correlation with visual 
field abnormalities is a powerful tool. Recently a study comparing the optic discs using 
optical coherence tomography (OCT) and Heidelberg retina topography (HRT) supports 
some of the differences (Shin et al., 2008). Disc appearance in NTG is traditionally divided 
into two sub-groups. The more common is the senile sclerotic group, which is characterized 
by a pale shallow sloping neuroretinal rim. These patients are often older in age and suffer 
from vascular diseases. The other group, focal ischemic, is characterized by deep focal 
notching of the rim. Splinter hemorrhages are a typical finding in NTG and imply in most 
cases a progressive disease (Drance et al., 2001; Jonas & Xu, 1994). Beta zone peripapillary 
atrophy has also been suggested related to optic nerve damage in NTG (Xia et al., 2005). The 
site of the hemorrhage may predict an area of notch development with a correlated visual 
field loss (Chumbley & Brubaker, 1976; Siegner & Netland, 1996; Tomita, 2000). Visual field 
patterns in NTG are similar to the ones seen in POAG, still some articles found differences 
in the distribution and shape of the scotomas. Scotomas observed in NTG visual fields often 
tend to be deeper, steeper and closer to fixation than in POAG patients (Caprioli & Spaeth, 
1984; Harrington, 1960). Some articles mainly from japan found that scotomas in NTG may 
be more predominant in the lower hemifield (Araie, 1995).  
The ophthalmologist should rule out "burned out" secondary glaucoma and other 
misleading diagnosis. Careful history and meticulous ophthalmic examination should look 
for previous trauma, uveitis, glaucomatocyclitic crisis, pigmentary glaucoma, previous 
topical or systemic steroid treatment, previous acute angle closure attack and the use of 
systemic medication that lowers IOP (e.g., beta-blockers). Compliance should be appreciated 
to rule out the possibility that the patient takes his anti-glaucoma medications only before 
the ophthalmologist examination in order to "please" their doctor. Non-glaucomatous optic 
disc abnormalities such as congenital colobomas, optic nerve pit, anterior ischemic optic 
neuropathy, traumatic optic neuropathy, optic nerve or chiasm compressing lesion, and 
various retinal abnormalities should be considered and revoked. The diagnosis and follow-
up of NTG is more challenging with hypoplastic and myopic tilted discs. Systemic 
evaluation is advised to identify diseases that are more frequent in NTG patients, and when 
the diagnosis is difficult. Blood pressure, ischemic vascular disease, perfusion pressure, 
vasospastic disorders (migraine, Raynaud phenomenon) and obstructive sleep apnea should 
be assessed in selected cases. Some cases may require neurological evaluation and 
hematological work-up to search for various neurological conditions or coagulopathies. 
Generally, systemic evaluation is reserved for atypical cases when the optic disc appearance 
and visual field do not correlate with glaucomatous damage, when glaucomatous damage is 
found with IOP lower than the high teens before treatment or when other neurological 
symptoms are present. Neurological examination is vital in all cases of NTG with atypical 
www.intechopen.com
 
Normal-Tension (Low-Tension) Glaucoma 
 
539 
clinical manifestation. Lesions such as meningiomas, craniopharingiomas, pituitary adenomas, 
and compressive vascular lesions such as aneurisms can mimic NTG. Some ophthalmic 
signs are more suggestive of a neurological disease and should prompt a neurological 
evaluation. Perhaps the most important of them is a rapid progression of the disease despite 
low IOP with or without treatment. Other signs that should raise suspicion are pale optic 
disks and poor best corrected visual acuity. Needless to say any neurologic symptoms 
prompt neurologic workup. Some authors believe that it is important in all cases of NTG to 
perform a CT scan (Gutman et al., 1993), though others found no value for a routine 
neurological examination in NTG patients (Kesler et al., 2010). 
Risk factors for the development of NTG in untreated patients that were found in the 
Collaborative Normal Tension Glaucoma Study (CNTGS) are migraine, female gender and 
splinter disc hemorrhage at the diagnosis (Drance et al., 2001). Age over 60 years is common 
(Klein et al., 1992), and a high prevalence was found in Japanese as mentioned earlier (Iwase 
et al., 2004; Shiose et al., 1991). Other risk factors found to be more prevalent in NTG than in 
POAG patients were ischemic vascular disease, obstructive sleep apnea, autoimmune 
diseases, and coagulopathies, but their effect on development of NTG was not consistent. 
The progression of glaucomatous damage in NTG is usually very slow. Collaborative 
Normal Tension Glaucoma Study (CNTGS) showed that half of the untreated patients did 
not progress in 5 years, and in most cases the progression was slow (Anderson, 2003). In 
some of these patients a previous hypotensive crisis from a massive bleeding or arrhythmia 
resulted in optic disk cupping. (Drance, 1977). In patients without a subsequent hypotensive 
crisis the glaucoma is not expected to progress. Other cases such as steroid responders or 
"burned out" pigmentary or uveitic glaucoma may not progress at all. Despite their effect as 
risk factors for the development of NTG, neither age nor untreated level of IOP affected the 
risk for progression in untreated eyes (Anderson, 2003). Disc hemorrhages, as mentioned 
earlier, where also found to be related to the progression of glaucomatous damage (Ishida et 
al., 2000). 
6. Practical steps for diagnosis 
It is difficult to diagnose NTG if the cup to disc ratio is over 0.5 even if the differences in 
cupping are 0.2 or higher in the presence of normal IOP. At this stage, the visual fields are 
usually normal. If the cornea is thin, POAG may be suspected after correction of the IOP 
according to the corneal thickness. But if the corneal thickness is normal, the diagnosis of 
NTG cannot be established. Those patients may stay with the diagnosis of glaucoma 
suspects until new signs of disk abnormalities appear that correlate with the glaucomatous 
visual field defects. Although these patients may deteriorate slowly, other glaucoma 
patients may deteriorate rather quickly. Therefore, it is recommended to follow individuals 
over the age of 40, glaucoma suspects and individuals with family history, at least every 6 
months. There have been cases were glaucoma appeared and progressed within less than a 
year, and this is the reason for a 6 months routine follow-up. Preperimetric normal tension 
glaucoma should be evaluated using FDT or Swap when available.  
The diagnosis is made when optic disc cupping and glaucomatous visual field defects are 
found in conjunction with normal IOP. POAG should be ruled out by corneal pachymetry and 
adjustment of the IOP to the corneal thickness. Other causes for optic disc cupping and visual 
field defects should be ruled out by detailed anamnesis (e.g., episodes of major blood loss) and 
further analysis (e.g., brain computed tomography to rule out tumors as mentioned earlier). 
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7. Treatment 
The decision to treat a patient suspected with NTG must include the patient's age and all 
aspects of the disease, its extent, pathogenic factors and especially the rate of progression. If 
the patient’s disease seems not to be progressive, monitoring of the disease is advised. When 
the disease is bilateral and not severe, treatment in one eye may be suitable. Careful follow-
up and comparison of both eyes for progression is essential. Some patients suffer from 
visual field loss and disc damage and require prompt therapy. As in POAG, it is customary 
to begin with medical therapy, but laser and even surgical treatment should be considered 
for advanced cases. The target IOP was recommended to be 30% reduction by CNTGS and 
this reduces the progression from 35% in untreated patients to 12% in the treated group. 
Approximately two-thirds of the patients that did not receive any therapy did not progress 
(Drance et al., 2001). Target IOP was reached with medication and laser trabeculoplasty in 
half of CNTGS patients. This was achieved without beta-blockers or prostaglandin analogs. 
Currently the available drugs are thought to produce better effects on lowering the IOP, 
better compliance and better results in preventing disease progression. Still some patients 
continue to deteriorate after proper IOP reduction. 
Some drops especially brimonidine were found to have neuroprotective effects in animal 
models (Vidal et al., 2010; Wolde Mussie et al., 2001). The research to achieve better control 
of glaucoma using a mechanism other than lowering IOP is promising. Unfortunately, 
neuroprotection by preventing the death of retinal ganglion cells, and vision preservation 
have not yet been proven in humans (Saylor et al., 2009). Long-term follow-up should 
determine whether or not neuroprotective agents may be beneficial for glaucoma patients 
(Sena et al., 2010). A low-tension glaucoma study LoGTS is currently underway comparing 
timolol and brimonidine treatment in NTG patients. The authors believe the neuroprotective 
effect of brimonidine will provide better results in preventing the disease progression. 
Dorzolamide, betaxolol, and latanaprost were considered to increase blood flow around the 
optic nerve (Harris et al., 1996, 2000), but newer published studies suggest that the effect, if 
exists at all, is minor (Bergstrand et al., 2002; Harris et al., 2003). Calcium channel blockers 
treatment was proved to be beneficial (Koseki et al., 2008; Netland et al., 1993). The 
treatment is recommended especially if a vasospastic disorder is diagnosed. Systemic side 
effects of calcium channel blockers such as flushing, edema, hypotension, headaches and 
reflex tachycardia requires careful selection of patients for this therapy. 
In patients with low compliance or troubling side effects, laser treatment should be 
considered. Selective laser trabeculoplasty has promising results on lowering IOP and is 
considered a safe and reproducible treatment for NTG (El Mallah et al., 2010; Realini, 2008). 
Argon laser trabeculoplasty was studied as treatment for normal-tension glaucoma patients. 
The results varied from little to no effect (Schulzer, 1992; Sharpe & Simmons, 1985). SLT is 
considered a safe and effective treatment for lowering IOP, especially in noncompliant 
patient and in patients with severe side effects from topical or systemic drug treatment.  
Trabeculectomy was found to lower IOP and slow the progression after long term follow-up 
(Bhandari et al., 1997; Shigeeda et al., 2002). Both medical and surgical treatments increase 
the risk for cataract formation. Cataract development was more frequent in patients 
undergoing trabeculectomy than in patients receiving only medical treatment (Drance et al., 
2001). Follow-up and cataract extraction is advisable to improve visual acuity and follow-up 
reliability. Finally any systemic disease that can affect optic nerve perfusion such as systemic 
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hypertension, congestive heart failure, arrhythmia and anemia, should be treated (Chumbley 
& Brubaker, 1976). 
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